• Pharma
  • March 19, 2025
  • 206 views
Milestone Pharma Expands Sale Agreement, Increases Offering

Milestone Pharmaceuticals Inc. (NASDAQ:MIST), a pharmaceutical company specializing in cardiovascular treatments with a market capitalization of $155.39 million, has amended its sales agreement with Jefferies LLC, effectively increasing its common…